Major Breakthrough in Pediatric Brain Cancer- First in 30 Years, One Mom’s Determination Pushes Through Chemo-Free Clinical Trial

Amber Larkin, Founder of Noah’s Light Foundation, received notification that the Food and Drug Administration (FDA) has granted The University of Texas MD Anderson Cancer Center approval to proceed with a new pediatric cancer treatment, called the NOAH Protocol. This investigative treatment aims at reducing and eliminating several types of pediatric brain cancer. The implications for groundbreaking results have not been achieved in over 30 years of research and development.

Read More